4621 - 4630 of 7665 Results
Title
Year
-
RESTRICTEDTitle: Immunotherapy in Parkinson’s disease: Current status and future directionsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 132Issue #:Start Page: 104587End Page: 104587Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104587Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104587Citation Count: 47
- Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice2019RESTRICTEDTitle: Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic miceJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-019-1636-8Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-019-1636-8Citation Count: 90
- Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing2019RESTRICTEDTitle: Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencingJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-019-0873-5Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-019-0873-5Citation Count: 35
- Miro1 Marks Parkinson’s Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson’s Models2019RESTRICTEDTitle: Miro1 Marks Parkinson’s Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson’s ModelsJournal Name: Cell MetabolismPublisher: Elsevier BVVol: 30Issue #: 6Start Page: 1131End Page: 1140.e7Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cmet.2019.08.023Best OA location URL: http://www.cell.com/article/S1550413119304978/pdfCitation Count: 102
-
RESTRICTEDTitle: Nonlinear Z‐score modeling for improved detection of cognitive abnormalityJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 11Issue #: 1Start Page: 797End Page: 808Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2019.08.003Best OA location URL: https://doi.org/10.1016/j.dadm.2019.08.003Citation Count: 14
- Organotypic slice culture model demonstrates inter-neuronal spreading of alpha-synuclein aggregates2019RESTRICTEDTitle: Organotypic slice culture model demonstrates inter-neuronal spreading of alpha-synuclein aggregatesJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-019-0865-5Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-019-0865-5Citation Count: 45
- Parkinson's disease‐associated dyskinesia in countries with low access to levodopa‐sparing regimens2019RESTRICTEDTitle: Parkinson's disease‐associated dyskinesia in countries with low access to levodopa‐sparing regimensJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 12Start Page: 1929End Page: 1930Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27891Citation Count: 3
- Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodies2019RESTRICTEDTitle: Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 69Issue #:Start Page: 119End Page: 124Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061324Citation Count: 28
- Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?2019RESTRICTEDTitle: Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?Journal Name: Molecular Genetics and MetabolismPublisher: Elsevier BVVol: 128Issue #: 4Start Page: 470End Page: 475Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ymgme.2019.10.001Citation Count: 25
-
RESTRICTEDTitle: Systemic Exosomal Delivery of shRNA Minicircles Prevents Parkinsonian PathologyJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 27Issue #: 12Start Page: 2111End Page: 2122Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ymthe.2019.08.010Best OA location URL: http://www.cell.com/article/S1525001619303715/pdfCitation Count: 129